Breadcrumb

Photo of Elias Chandran

Elias Chandran, MBBS, FRACP

  • Center for Cancer Research
  • National Cancer Institute
Assistant Research Physician
Genitourinary Malignancies Branch

RESEARCH SUMMARY

Dr. Elias Chandran is a Medical Oncologist with specialist experience and interest in bladder cancer and rare genitourinary malignancies such as penile cancer. He also as a specific interest in mismatch repair deficiency and microsatellite instability. His research is focused on development of new therapeutic strategies for these malignancies, including the novel use of immunotherapies and investigational therapeutic agents such as antibody-drug conjugates.

Areas of Expertise

Medical Oncology
Genitourinary Malignancies
Penile Cancer
Testicular Cancer

Publications

Mismatch repair deficiency and microsatellite instability in urothelial carcinoma: a systematic review and meta-analysis

Elias B A Chandran, Giovanni Maria Iannantuono, Saad O Atiq, Dilara Akbulut, Ninet Sinaii, Nicholas I Simon, Abdul Rouf Banday, Salah Boudjadi, Sandeep Gurram, Amin H Nassar, Jonathan E Rosenberg, Gisela Butera, Min Yuen Teo, Guru Sonpavde 8, Jonathan A Coleman, Andrea B Apolo
BMJ Oncology. 3(1):e000335: e000335, 2024.

Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors

Andrea B Apolo, Daniel M Girardi, Scot A Niglio, Rosa Nadal, Andre R Kydd, Nicholas Simon, Lisa Ley, Lisa M Cordes, Elias Chandran, Seth M Steinberg, Sunmin Lee, Min-Jung Lee, Shraddha Rastogi, Nahoko Sato, Liang Cao, A Rouf Banday, Salah Boudjadi, Maria J Merino, Antoun Toubaji, Dilara Akbulut, Bernadette Redd, Hadi Bagheri, Rene Costello, Sandeep Gurram, Piyush K Agarwal, Heather J Chalfin, Vladimir Valera, Howard Streicher, John Joseph Wright, Elad Sharon, William D Figg, Howard L Parnes, James L Gulley, Biren Saraiya, Sumanta K Pal, David Quinn, Mark N Stein, Primo N Lara, Donald P Bottaro, Amir Mortazavi
Journal of Clinical Oncology. 2024 Jul 2:JCO2302233: JCO2302233, 2024.

Two cycles of adjuvant carboplatin for clinical stage 1 testicular seminoma in New Zealand centres: A retrospective analysis of efficacy and long-term events

Elias A Chandran, Aaron Chindewere, Richard North, Michael B Jameson
Cancer Reports. 2021 Apr;4(2):e1310: e1310,

Efficacy and safety of PARP inhibitors in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis of clinical trials

Giovanni Maria Iannantuono, Elias Chandran, Charalampos S Floudas, Hyoyoung Choo-Wosoba, Gisela Butera, Mario Roselli, James L Gulley, Fatima Karzai
Cancer Treatment Reviews. 2023 Nov:120:102623: 2023.

Signaling new therapeutic opportunities: cytokines in prostate cancer

Elias Chandran, Luke Meininger, Fatima Karzai, Ravi A Madan
Expert Opinion on Biological Therapy. 2022 Oct;22(10):1233-1243: 2022.